IPO

Global Health Limited IPO

Mainboard

Non Banking Financial Company (NBFC)

Listed On: Nov 16, 2022 at ₹ 401.0(NSE)

₹ 14784 /44 Shares

Check Allotment

03 Nov, 2022

Open Date

07 Nov, 2022

Close Date

11 Nov, 2022

Allotment Date

16 Nov, 2022

Listing Date
Price Summary

Last Closing

1,154.00 (243.45%)

52 Week High

1,456.50

52 Week Low

996.45

Last Update

12-Dec-2025 3:30 PM
Global Health IPO Issue Details
  • Issue Price ₹319-336 per equity share
  • Face Value ₹2 Per Equity Share
  • Issue Price Approx 2,205.57 Cr. + Fresh : ₹500 Cr + OFS : 50,761,000 Shares
  • Listing at BSE, NSE
  • List Price 401.0(NSE)
  • Listing Date 2022-11-16
  • Lead Manager Kotak Mahindra Capital Company Limited, Credit Suisse Securities (India) Private Limited, Jefferies India Private Limited, JM Financial Consultants Private Limited
  • Registrar KFin Technologies Limited
Global Health IPO Details
  • Retail Portion 35% (Number of Retail Applications : 5,22,150 Approx),
    (Number of sHNI Applications : 5,320 Approx),
    (Number of bHNI Applications : 10,650 Approx)
Global Health IPO Documents
DRHP
RHP
Global Health IPO Details


The IPO of Global Health is priced at ₹319-336 per equity share, which has a face value of ₹2 Per Equity Share each, IPO bidding starts from Nov 3, 2022 and ends on Nov 7, 2022. The allotment for Global Health IPO will be finalized on Nov 11, 2022. Global Health IPO will be listed on BSE, NSE, with a tentative listing date fixed as Nov 16, 2022. The company shall list its equity shares on the BSE, NSE. KFin Technologies Limited is the registrar of the issue.

The book-running lead manager for the IPO is/are Kotak Mahindra Capital Company Limited, Credit Suisse Securities (India) Private Limited, Jefferies India Private Limited, JM Financial Consultants Private Limited.


The Global Health IPO sets its price band at 319-336 for each share. A single application for Global Health Limited IPO must contain at least 44 shares.

Read More
Global Health IPO Subscription Analysis And Details
Retail
0.88x
QIB
28.64x
NII
4.02x
bNII
5.16x
sNII
1.73x
Total
9.58x
As on QIB NII
bNII   sNII 		Retail Total
Shares Offered / Reserved 5,956,362 4,625,749
3,083,832    1,541,917 		10,793,414 21,375,525
Day 1 03-11-22 05:00 PM
0.54 x 0.18
0.22 x   0.11 x 		0.12 x 0.26 x
Day 2 04-11-22 05:00 PM
0.56 x 0.96
1.30 x   0.30 x 		0.25 x 0.49 x
Day 3 07-11-22 05:00 PM
28.64 x 4.02
5.16 x   1.73 x 		0.88 x 9.58 x
Total No of Applications
300851
Global Health Valuations
Earnings Per Share (EPS) ₹7.78/-
P/E Ratio N/A
RoNW 12.14%
Net Asset Value (NAV) - As on 31.03.22 ₹63.82
Global Health Company Financials
In Crs.
In Cr.
30-Jun-22 31-Mar-22 31-Mar-21 31-Mar-20
Assets 3221.94 3145.52 2694.1 2666.29
Revenue 626.54 2205.82 1478.16 1544.27
Profit After Tax 58.71 196.2 28.8 36.33
About Global Health Company

Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.

As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.

Read More
Global Health - Promoter(s)

Dr. Naresh Trehan

Pre Issue Share Holding : 35%

Post Issue Share Holding : 33%

Global Health IPO - Issue Objectives
1

Repayment/prepayment of borrowings, in full or part, of the Subsidiaries, GHPPL and MHPL.

2

General corporate purposes.

Global Health IPO - Anchor Investors

Medanta mobilises Rs 661 crore via anchor book ahead of IPO.
Marquee investors participated in the offer included the Government of Singapore, Marquee investors participated in the offer included the Government of Singapore, Monetary Authority of Singapore, Nomura Trust, Stichting Depositary APG Emerging Markets Equity Pool, Ontario Teachers' Pension Plan Board, Polar Capital Funds Plc, Government Pension Fund Global, Cohesion MK Best Ideas, and Affin Hwang INR Flexi Fund.
Domestic investors such as HDFC Mutual Fund, SBI Mutual Fund, ICICI Prudential, Axis Mutual Fund, Nippon Life, SBI Life Insurance, Edelweiss, Max Life Insurance, Motilal Oswal Mutual Fund, Aditya Birla Sun Life, HDFC Life Insurance, Canara Robeco Mutual Fund, and L&T Mutual Fund also invested in the company via anchor book.